A newly-released report by Future Market Insights reveals promising growth for the global endotracheal tube market, which is projected to reach a valuation of USD 4.5 Billion by 2033, up from USD 2.3 Billion in 2023. With a Compound Annual Growth Rate (CAGR) of 6.8% from 2023 to 2033, the market is being propelled by the increasing demand for surgical procedures and significant advancements in endotracheal intubation technology.
One of the key drivers for this growth is the rise in surgical procedures worldwide. According to the Global Surgery and Anaesthesia Statistics, approximately 313 million elective surgeries are conducted annually, creating a high demand for endotracheal tubes, which are essential for maintaining an open airway during surgery. These tubes play a critical role in emergency treatment applications, with this segment expected to generate the highest revenue growth, experiencing an impressive CAGR of 7.3% from 2023 to 2033.
In response to growing concerns over patient safety, medical device manufacturers have been innovating to minimize the risks associated with prolonged endotracheal tube usage, particularly the risk of Ventilator-Associated Pneumonia (VAP). Prolonged intubation, especially in patients on a ventilator or undergoing proning for over 48 hours, increases the likelihood of developing VAP. As a result, companies are integrating antithrombotic and antibacterial features into their products to help mitigate these risks. Medtronic’s Shiley Evac endotracheal tubes, for example, are reported to reduce VAP occurrence by 50%, offering a safer alternative for patients in critical care.
The ongoing medical advancements in endotracheal tube design, combined with an increase in surgical volume and a greater focus on patient safety, are set to continue driving the growth of the endotracheal tube market in the coming years.
Here are the key takeaways from the newly-released Endotracheal Tube Market analysis report by Future Market Insights:
- Global Market Growth: The global Endotracheal Tube market held a valuation of USD 2.3 billion in 2023 and is projected to grow at a CAGR of 6.8%, reaching USD 4.5 billion by 2033.
- Revenue-Generating Segment: The Emergency Treatment application is expected to be the highest revenue-generating segment, with a projected CAGR of 7.3% from 2023 to 2033.
- United States Market:
- The U.S. market is forecast to grow at a CAGR of 6.7%, with an absolute dollar opportunity of USD 654.2 million.
- Growth drivers include an increase in chronic respiratory diseases (cardiovascular, respiratory disorders, diabetes, cancer, etc.), rising demand for ventilator-associated pneumonia treatments, and the growing geriatric population.
- Limitations include postoperative complications from endotracheal intubation and a shortage of trained professionals.
- United Kingdom Market:
- The UK market is expected to reach a valuation of USD 202.3 million by 2033, growing at a CAGR of 7.5%, with an absolute dollar opportunity of USD 103.5 million.
- Japan Market:
- Japan’s market is projected to grow at a CAGR of 6.4%, reaching USD 645.5 million by 2033, with an absolute dollar opportunity of USD 359 million.
These key factors highlight strong growth in the global and regional Endotracheal Tube markets, driven by medical advancements and increasing demand for treatment in emergency care, especially for chronic respiratory conditions.
Soaring Demand for Market Information: Uncover Detailed Trends and Insights in Our Report!
Competitive Analysis:
Prominent players including Teleflex Corporation, Medtronic, Medline Industries, Venner Medical, Sonoma Pharmaceuticals, Hospiteknik Healthcare, Armstrong Medical, Airway Innovations, and Smith’s Group lead the market.
Notable recent developments from key Endotracheal Tube providers include:
- In April 2020, Hydromer partnered with N8 Medical to become the official coating and manufacturing partner for the CeraShield Endotracheal Tube, designed for mechanically ventilated COVID-19 patients across Canada.
- In August 2020, Bactiguard’s endotracheal tubes, aimed at preventing COVID-19 infections, were granted approval from Health Canada under an Interim Order. This innovative device helps reduce the risk of secondary infections in critically ill patients.
Market Segments Covered in Endotracheal Tube Market Analysis:
By Product Type:
- Regular Endotracheal Tube
- Reinforced Endotracheal Tube
- Preformed Endotracheal Tube
- Double lumen Endotracheal Tube
By Route Type:
- Orotracheal
- Nasotracheal
By Application:
- Emergency Treatment
- Therapy
- Other Applications
By End-use:
- Hospitals
- Clinics
- Ambulatory Surgical Centres
- Other End-uses
By Region:
- North America
- Latin America
- Europe
- APAC
- Middle East & Africa
𝖤𝗑𝗉𝗅𝗈𝗋𝖾 𝖥𝖬𝖨’𝗌 𝖱𝖾𝗅𝖺𝗍𝖾𝖽 𝖮𝗇𝗀𝗈𝗂𝗇𝗀 𝖢𝗈𝗏𝖾𝗋𝖺𝗀𝖾 𝗈𝗇 𝖧𝖾𝖺𝗅𝗍𝗁𝖼𝖺𝗋𝖾 𝖬𝖺𝗋𝗄𝖾𝗍 𝖨𝗇𝗌𝗂𝗀𝗁𝗍𝗌 𝖣𝗈𝗆𝖺𝗂𝗇:
Weight Loss and Obesity Management Industry
Tattoo Removal Lasers Industry
Gastroesophageal Reflux Disease (GERD) Devices Industry
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube